Scientists have long known melanin - the pigments that give colour to skin, hair and eyes - has numerous useful qualities, including providing protection from cancer-causing ultraviolet (UV) radiation.
Due to its inherently disordered structure, however, attempts at recreating it in the laboratory have been thwarted.
A group of scientists, including researchers from the University of Strathclyde in the UKand City University of New York (CUNY), have developed a new approach for producing materials that not only mimic the properties of melanin, but also provide unprecedented control over them.
Unlike other biopolymers, such as DNA and proteins, where a direct link exists between the polymers' ordered structures and their properties, the structure of melanin is inherently disordered.
As a result directly relating structure to function is not possible, meaning researchers have been unable to fully exploit melanin's properties.
To overcome this, the research team used simple version of proteins - tripeptides consisting of just three amino acids - to produce molecular architectures with precisely controlled levels of order and disorder.
Subsequently, in-depth characterisation of the approach demonstrated that further properties, such as UV absorbance and nanoscale morphology of the melanin-like materials, could also be systematically controlled by the amino acid sequence of the tripeptide.
Tell Tuttle, Director of Research in the Department of Pure and Applied Chemistry at Strathclyde, employed computational technologies to characterise these materials and understand how these different structures could be created from the smaller building blocks of tripeptides.
"This project combined the ASRC's world-class facilities and experimental expertise with our computational expertise and the ARCHIE-WeSt supercomputer based at Strathclyde to produce materials that in many ways are better than melanin due to the control that we can exercise over them."
The researchers are also pursuing commercialisation of this new technology, which includes near-term possibilities in cosmetics and biomedicine.
The discovery was published today in the journal "Science".
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
